SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-231552
Filing Date
2023-09-08
Accepted
2023-09-08 16:16:25
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d517801ds3.htm S-3 146669
2 EX-5.1 d517801dex51.htm EX-5.1 10724
3 EX-23.1 d517801dex231.htm EX-23.1 1656
4 EX-FILING FEES d517801dexfilingfees.htm EX-FILING FEES 10634
5 GRAPHIC g517801g03a03.jpg GRAPHIC 83247
6 GRAPHIC g517801g0906210555914.jpg GRAPHIC 13990
7 GRAPHIC g517801g0906210556125.jpg GRAPHIC 5347
  Complete submission text file 0001193125-23-231552.txt   312395
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274423 | Film No.: 231245496
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences